ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 301 for:    complementary and alternative medicine

The Use of Alternative Medicine by Palliative Care Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03260946
Recruitment Status : Recruiting
First Posted : August 24, 2017
Last Update Posted : August 24, 2017
Sponsor:
Information provided by (Responsible Party):
Hospices Civils de Lyon

Brief Summary:

Palliative care centres in Lyon, France as well as the disclosure of Complementary and Alternative Medicine and conventional healthcare use to conventional and Complementary and Alternative Medicine practitioners respectively.

These aims will be achieved through the following objectives:

  1. Describe the prevalence of Complementary and Alternative Medicine practitioner and product use in the outpatient population of palliative care centres in Lyon, France
  2. Describe the characteristics of Complementary and Alternative Medicine users the outpatient population of palliative care centres in Lyon, France
  3. Estimate the Complementary and Alternative Medicine expenditure of the outpatient population of palliative care centres in Lyon, France
  4. Describe the rates of disclosure of both Complementary and Alternative Medicine and conventional health care to health professionals by the outpatient population of palliative care centres in Lyon, France
  5. Describe the reasons for disclosure or non-disclosure of both Complementary and Alternative Medicine and conventional health care to health professionals by the outpatient population of palliative care centres in Lyon, France

Condition or disease Intervention/treatment
Cancer Terminal Cancer Other: Complementary medicine use

Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Use of Complementary Medicine in Palliative/Supportive Care Centres in Lyon, France
Actual Study Start Date : July 11, 2017
Estimated Primary Completion Date : July 11, 2018
Estimated Study Completion Date : July 11, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Palliative Care

Group/Cohort Intervention/treatment
Palliative/Supportive care
Individuals with cancer receiving palliative or supportive care
Other: Complementary medicine use
The prevalence of complementary medicine use




Primary Outcome Measures :
  1. Complementary medicine use [ Time Frame: 15 minutes ]
    The prevalence of complementary medicine use. Data collected using a questionnaire.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals with cancer receiving palliative or supportive care
Criteria

Inclusion Criteria:

  1. Patients accessing care from a palliative/supportive care centre in Lyon, France
  2. Can read and understand French
  3. Has been diagnosed with cancer

Exclusion Criteria:

  1. The primary health condition for which they are attending the centre is not cancer
  2. They are not able to read and understand French

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03260946


Contacts
Contact: Marilène FILBET, Pr 0478861482 ext +33 marilene.filbet@chu-lyon.fr

Locations
France
USP de Charmettes - Croix rouge française Recruiting
Lyon, France, 69006
Contact: Henri NAHAPETIAN, Dr    04.72.74.61.03 ext +33    henri.nahapetian@croix-rouge.fr   
Principal Investigator: Henri NAHAPETIAN, Dr         
Service E.M.S.P. Groupement Hospitalier Nord - Hôpital de la Croix-Rousse Recruiting
Lyon, France, 69317
Contact: Myriam LEGENNE, Dr    04 78372579 ext +33    myriam.legenne@chu-lyon.fr   
Principal Investigator: Myriam LEGENNE, Dr         
Centre de Soins Palliatifs Lyon-Sud Pavillon 1K - Centre Hospitalier Lyon-Sud Recruiting
Pierre-Bénite, France, 69495
Contact: Marilène FILBET, Pr    0478861482 ext +33    marilene.filbet@chu-lyon.fr   
Principal Investigator: Marilène FILBET, Pr         
Sponsors and Collaborators
Hospices Civils de Lyon

Responsible Party: Hospices Civils de Lyon
ClinicalTrials.gov Identifier: NCT03260946     History of Changes
Other Study ID Numbers: 69HCL17_0217
First Posted: August 24, 2017    Key Record Dates
Last Update Posted: August 24, 2017
Last Verified: August 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No